Solid State NMR Studies of Amyloid Proteins
淀粉样蛋白的固态核磁共振研究
基本信息
- 批准号:10446323
- 负责人:
- 金额:$ 70.95万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-08-01 至 2027-05-31
- 项目状态:未结题
- 来源:
- 关键词:2,4-DinitrophenolAducanumabAlzheimer&aposs DiseaseAlzheimer&aposs disease brainAmino AcidsAmyloidAmyloid FibrilsAmyloid ProteinsAmyloid beta-ProteinAmyloidosisAntibodiesArctic mutationBindingBiological ModelsBrainChemicalsComputer softwareCryoelectron MicroscopyDetectionDevelopmentDialysis procedureEarly Onset Alzheimer DiseaseExhibitsFrequenciesGenetic PolymorphismGrantGrowthHydration statusInvestigationIsotopesLabelMagicMeasurementMeasuresMethodologyMethodsModelingMolecular StructureMorphologyN-terminalNMR SpectroscopyPathologicPeptidesPolymorphPopulationPrPProcessProteinsPublishingReproducibilityResearchResolutionSamplingSeedsSignal TransductionSpectrum AnalysisStructureSystemTailTechniquesTestingThermodynamicsTorsionVariantamyloid peptideamyloid structurebeta-2 Microglobulincatalystexperimental studyflexibilityin vivomethod developmentmutantnext generationparagonsolid state nuclear magnetic resonancesup35toolyeast prion
项目摘要
Project Summary/Abstract
The proposed research focuses on the application and development of magic angle spinning (MAS) NMR
as a tool for structural investigations of amyloid peptides and proteins. The research covers four major
topics.
A. Structure of Amyloid Peptides and Proteins
(1) Aβ1-42 and Aβ1-40: Using 1H detected and DNP magic angle spinning (MAS) and cryoEM we plan the
following experiments on Aβ: (a) a determination of the structure of Aβ1-40; (b) the structure of the
pathologically important plaque seeded Aβ1-42; (c) the structure of the N-terminal tail and the binding of
antibody Aducanumab to the tail; (d) and the structure of mutants for Aβ1-42.
(2) Beta-2-microglobulin (β2m) and DeltaN6-β2m: We plan to determine the structure of the 93 AA β2m-DeltaN6 variant of the dialysis related amyloidosis (DRA) protein. In addition, DeltaN6 is thought to be the
catalyst that seeds β2m plaques in-vivo. We therefore also intend to study mixtures of β2m and DeltaN6.
(3) Amyloid polymorphism: We intend to determine the structure of the three polymorphs of the
amyloidiogenic peptide GNNQQNY from Sup35. These are present in a consistent 1:1:1 population
and will provide the first study of the manner in which defined structural changes alter 13C and 15N
shifts. 1H, 13C and 17O NMR will be used to characterize the structure around the H2O molecules in
the GNNQQNY lattice.
B. NMR methods None of the above structural studies would be possible absent NMR methods to assign
spectra, measure distances and torsion angles, to enhance signal intensities, etc. We therefore plan
to continue the development of the methods essential for these structural investigations. (a) We plan
to continue these experiments by initially preparing U-17O/13C/15N GNNQQNY to further develop the
spectroscopy and then to apply it to spectroscopy of Aβ1-42 and Aβ1-40. The experiments will employ 1H
detection and DNP in order to optimize the sensitivity. PAR and PAIN have been essential to MAS
NMR structure determinations but they are semiquantitative methods to measure 13C-13C and 13C-15N
distances. Using SPINEVOLUTION software and experiments on model systems, we plan to develop
these approaches into quantitative distance measurement techniques.
项目概要/摘要
拟研究重点是魔角旋转(MAS)核磁共振的应用和发展
AS 淀粉样肽和蛋白质结构研究的工具该研究涵盖四个主要领域。
话题。
A. 淀粉样肽和蛋白质的结构
(1) Aβ1-42 和 Aβ1-40:使用 1 小时检测和 DNP 魔角旋转 (MAS) 和 Cryoem 我们计划
以下关于 Aβ 的经验: (a) Aβ1-40 结构的测定;
病理学上重要的斑块种子 Aβ1-42;
尾部抗体 Aducanumab;
(2)BETA-2-微球蛋白(β2m)和Delta6-β2m:我们计划确定透析相关S(Dra)蛋白的93AAβ2m-Deltan6变体的结构。这
体内产生 β2m 斑块的催化剂我们还研究了 β2m 和 Delta6 的混合体。
(3)淀粉样蛋白多态性:我们打算确定淀粉样蛋白的三种多晶型物的结构
来自 SUP35 的淀粉样肽 GNNQQNY 存在于一致的 1:1:1 群体中。
并将首次研究定义的结构变化改变 13c 和 15N 的方式
1h、13c 和 17O NMR 将用于表征 H2O 分子周围的结构。
Gnnqqny晶格。
B. NMR 方法 如果没有 NMR 方法进行分配,上述结构研究都是不可能的
光谱、测量距离和扭转角、增强信号强度等。我们的 THEREFORE PLAN
继续开发结构投资所必需的方法。
为了继续这些实验,首先准备 U-17O/13c/15N GNNQQNY,以进一步开发
光谱分析,然后将其应用于 Aβ1-42 和 Aβ1-40 的光谱分析,实验将使用 1 小时。
检测和 DNP 以优化灵敏度。
NMR 结构测定,但它们是测量 13c-13C 和 13C-15N 的半定量方法
我们计划使用 SPINEVOLUTION 软件并在模型系统上进行实验来开发
这些方法涉及定量距离测量技术。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ROBERT Guy GRIFFIN其他文献
ROBERT Guy GRIFFIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ROBERT Guy GRIFFIN', 18)}}的其他基金
Q-band Upgrade to an X-band Pulsed EPR spectrometer
Q 波段升级为 X 波段脉冲 EPR 光谱仪
- 批准号:
10177244 - 财政年份:2021
- 资助金额:
$ 70.95万 - 项目类别:
Cryoprobe repairs and amplifier replacement for the 800 and 750 MHz spectrometers
800 和 750 MHz 光谱仪的冷冻探针维修和放大器更换
- 批准号:
10400474 - 财政年份:2019
- 资助金额:
$ 70.95万 - 项目类别:
U.S.-Canada Winter School on Biomolecular Solid State NMR
美国-加拿大生物分子固态核磁共振冬季学校
- 批准号:
9398504 - 财政年份:2017
- 资助金额:
$ 70.95万 - 项目类别:
相似海外基金
A 5-HTergic DRN vCA1 circuit and Alzheimer's disease
5-HTergic DRN vCA1 回路与阿尔茨海默病
- 批准号:
10740050 - 财政年份:2023
- 资助金额:
$ 70.95万 - 项目类别:
Targeting MSUT2 with small molecules to ameliorate pathological tau
用小分子靶向 MSUT2 改善病理性 tau
- 批准号:
10735826 - 财政年份:2023
- 资助金额:
$ 70.95万 - 项目类别:
Perivascular Inflammation and Vascular Remodeling: A Common Cause of Hemorrhage in Cerebral Small Vessel Diseases?
血管周围炎症和血管重塑:脑小血管疾病出血的常见原因?
- 批准号:
10861499 - 财政年份:2023
- 资助金额:
$ 70.95万 - 项目类别:
Innovative precision medicine methods in subgroup identification for Alzheimer's disease
阿尔茨海默病亚组鉴定的创新精准医学方法
- 批准号:
10740649 - 财政年份:2023
- 资助金额:
$ 70.95万 - 项目类别:
Development of a novel, regenerative therapy to reverse synapse loss in Alzheimer's Disease
开发一种新颖的再生疗法来逆转阿尔茨海默氏病的突触损失
- 批准号:
10707700 - 财政年份:2023
- 资助金额:
$ 70.95万 - 项目类别: